Rush University Medical Center, Professional Office Building Infusion Pharmacy — Chicago, Illinois

Rush University Medical Center, Professional Office Building Infusion Pharmacy is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Rush University Medical Center, Professional Office Building Infusion Pharmacy has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Early Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush University Medical Center, Professional Office Building Infusion Pharmacy?

Rush University Medical Center, Professional Office Building Infusion Pharmacy has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush University Medical Center, Professional Office Building Infusion Pharmacy conducted?

Rush University Medical Center, Professional Office Building Infusion Pharmacy has 2 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer, Early Breast Cancer.

Is Rush University Medical Center, Professional Office Building Infusion Pharmacy accredited by Crixeo Health?

Rush University Medical Center, Professional Office Building Infusion Pharmacy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rush University Medical Center, Professional Office Building Infusion Pharmacy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.